OTC:PTPI | Profit Breakdown | Petros Pharmaceuticals, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$988,501.00-$955,625.00-$955,625.00
2026-03-31-$1.03M-$987,036.00-$987,036.00
2025-12-31-$391,486.00-$336,506.00-$336,506.00
2025-09-30-$990,737.00-$922,723.00-$922,723.00
2025-06-30-$1.8M-$2.04M$5.43M
2025-03-31-$1.46M-$1.2M-$2.26M
2024-12-31$725,403.00$460,649.00-$577,554.00-$552,813.00-$9.27M
2024-09-30$1.58M$1.29M-$1.2M-$919,541.00-$2.22M
2024-06-30$1.42M$1.09M-$1.35M$384,288.00-$662,026.00
2024-03-31$1.39M$1.06M-$1.5M$382,893.00-$2.16M
2023-12-31-$364,250.00-$522,397.00-$5.04M$318,150.00$318,150.00
2023-09-30$1.67M$1.27M-$4.81M-$4.55M-$4.55M
2023-06-30$1.99M$1.48M-$2.46M-$2.55M-$2.55M
2023-03-31$2.52M$1.97M-$1.31M-$1.39M-$1.39M
2022-12-31$798,101.00-$83,231.00-$4.1M-$4.23M-$4.22M
2022-09-30-$1.74M-$13.67M-$13.82M-$13.83M
2022-06-30$4.19M$3.54M-$1.66M-$1.81M-$1.81M
2022-03-31$2.47M$1.99M-$481,198.00-$174,224.00
2021-12-31-$867,160.00-$1.11M-$7.97M-$8.19M-$8.19M
2021-09-30$2.15M$1.83M-$3.6M-$1.69M-$1.7M
2021-06-30$2.46M$2.06M-$4.28M-$2.11M-$2.11M
2021-03-31$4.08M$3.43M-$2.2M$3.01M$3.01M
2020-12-31$2.93M$1.19M-$4.32M-$6.82M-$5.44M
2020-09-30$3.46M$2.48M-$2.34M-$3.31M-$3.3M
2020-06-30$1.37M$834,333.00-$5.02M-$5.78M-$5.76M
2020-03-31$1.79M$1.01M-$5.61M-$6.11M-$6.08M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31-$4.64M-$4.5M$1.91M
2024-12-31$5.11M$3.9M-$4.63M-$705,174.00-$14.32M
2023-12-31$5.82M$4.19M-$13.62M-$8.16M-$8.16M
2022-12-31$5.99M$3.7M-$19.92M-$20.04M-$20.04M
2021-12-31$7.81M$6.21M-$18.05M-$8.99M-$8.99M
2020-12-31$9.56M$5.51M-$17.28M-$22.01M-$20.59M